Gene-expression of metastasized versus non-metastasized primary head and neck squamous cell carcinomas: A pathway-based analysis

BMC Cancer

Volumn 8, Issue , 2008, Pages

  Hensen, Erik F ^a   De Herdt, Maria J ^a   Goeman, Jelle J ^a   Oosting, Jan ^a   Smit, Vincent T H B M ^a   Cornelisse, Cees J ^a   Baatenburg de Jong, Robert J ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; MATRIX METALLOPROTEINASE; UROKINASE;

ARTICLE; CANCER INVASION; CARCINOGENESIS; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION; GENE PROBE; GENETIC DATABASE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; MICROARRAY ANALYSIS; NEOVASCULARIZATION (PATHOLOGY); NUCLEOTIDE SEQUENCE; ONCOGENE; REFERENCE DATABASE; SQUAMOUS CELL CARCINOMA; VALIDATION STUDY; COMPARATIVE STUDY; GENETICS; HEAD AND NECK TUMOR; METASTASIS;

CARCINOMA, SQUAMOUS CELL; GENE EXPRESSION; HEAD AND NECK NEOPLASMS; HUMANS;

EID: 46349097797     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-8-168     Document Type: Article

References (41)

1. Baatenburg de Jong RJ Hermans J Molenaar J Briaire JJ Le Cessie S Prediction of survival in patients with head and neck cancer Head Neck 2001, 23(9):718-724. 10.1002/hed.1102 11505480
2. Mamelle G Pampurik J Luboinski B Lancar R Lusinchi A Bosq J Lymph node prognostic factors in head and neck squamous cell carcinomas Am J Surg 1994, 168(5):494-498. 10.1016/S0002-9610(05)80109-6 7977983
3. Roepman P Wessels LF Kettelarij N Kemmeren P Miles AJ Lijnzaad P Tilanus MG Koole R Hordijk GJ Vliet van der PC Reinders MJ Slootweg PJ Holstege FC An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas Nat Genet 2005, 37(2):182-186. 10.1038/ng1502 15640797
4. Järvinen AK Hautaniemi S Edgren H Auvinen P Saarela J Kallioniemi OP Monni O Are data from different gene expression microarray platforms comparable? Genomics 2004, 83(6):1164-1168. 10.1016/j.ygeno.2004.01.004 15177569
5. Tan PK Downey TJ Spitznagel EL Jr Xu P Fu D Dimitrov DS Lempicki RA Raaka BM Cam MC Evaluation of gene expression measurements from commercial microarray platforms Nucleic Acids Res 2003, 31(19):5676-84. 206463 14500831 10.1093/nar/gkg763
6. Irizarry RA Warren D Spencer F Kim IF Biswal S Frank BC Gabrielson E Garcia JG Geoghegan J Germino G Griffin C Hilmer SC Hoffman E Jedlicka AE Kawasaki E Martínez-Murillo F Morsberger L Lee H Petersen D Quackenbush J Scott A Wilson M Yang Y Ye SQ Yu W Multiple-laboratory comparison of microarray platforms Nat Methods 2005, 2(5):345-50. 10.1038/nmeth756 15846361
7. Kuo WP Jenssen TK Butte AJ Ohno-Machado L Kohane IS Analysis of matched mRNA measurements from two different microarray technologies Bioinformatics 2002, 18(3):405-12. 10.1093/bioinformatics/18.3.405 11934739
8. Kothapalli R Yoder SJ Mane S Loughran TP Jr Microarray results: How accurate are they? BMC Bioinformatics 2002, 3:22. 126254 12194703 10.1186/1471-2105-3-22
9. Ein-Dor L Kela I Getz G Givol D Domany E Outcome signature genes in breast cancer: Is there a unique set? Bioinformatics 2005, 21(2):171-8. 10.1093/bioinformatics/bth469 15308542
10. Roepman P Kemmeren P Wessels LF Slootweg PJ Holstege FC Multiple robust signatures for detecting lymph node metastasis in head and neck cancer Cancer Res 2006, 66(4):2361-2366. 10.1158/0008-5472.CAN-05-3960 16489042
11. Ogata H Goto S Sato K Fujibuchi W Bono H Kanehisa M KEGG: Kyoto Encyclopedia of Genes and Genomes Nucleic Acids Res 1999, 27(1):29-34. 148090 9847135 10.1093/nar/27.1.29
12. Kyoto Encyclopedia of Genes and Genomes (KEGG) http://www.genome.jp/kegg
13. Biocarta website http://www.biocarta.com
14. Manoli Th Gretz N Gröne HJ Kenzelmann M Eils R Brors B Group testing for pathway analysis improves comparability of different microarray datasets Bioinformatics 2006, 22(20):2500-2506. 10.1093/ bioinformatics/btl424 16895928
15. Nature Genetics website http://www.nature.com/ng
16. NCBI Gene Expression Omnibus (GEO) website http://www.ncbi.nlm.nih.gov/ geo
17. Wu Z Irizarry RA Gentleman R Martinez-Murillo F Spencer F A Model-Based Background Adjustment for Oligonucleotide Expression Arrays J Am Stat Assoc 2004, 99(468):909-917. 10.1198/016214504000000683
18. Dai M Wang P Boyd AD Kostov G Athey B Jones EG Bunney WE Myers RM Speed TP Akil H Watson SJ Meng F Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data Nucleic Acids Res 2005, 33(20):e175. 1283542 16284200 10.1093/nar/gni179
19. Gentleman RC Carey VJ Bates DM Bolstad B Dettling M Dudoit S Ellis B Gautier L Ge Y Gentry J Hornik K Hothorn T Huber W Iacus S Irizarry R Leisch F Li C Maechler M Rossini AJ Sawitzki G Smith C Smyth G Tierney L Yang JYH Zhang J Bioconductor: Open software development for computational biology and bioinformatics Genome Biol 2004, 5(10):R80. 545600 15461798 10.1186/gb-2004-5-10-r80
20. Bioconductor website http://www.bioconductor.org
21. Smyth GK Linear models and empirical Bayes methods for assessing differential expression in microarray experiments Stat Appl Genet Mol Biol 2004, 3:ARticle 3. 16646809
22. Benjamini Y Hochberg Y Controlling the false discovery rate: A practical and powerful approach to multiple testing J Royal Stat Soc B 1995, 57:289-300.
23. Fidler IJ The pathogenesis of cancer metastasis: The 'seed and soil' hypothesis revisited Nat Rev Cancer 2003, 3(6):453-458. 10.1038/nrc1098 12778135
24. Goeman JJ Geer van de SA de Kort F van Houwelingen HC A global test for groups of genes: Testing association with a clinical outcome Bioinformatics 2004, 20(1):93-99. 10.1093/bioinformatics/btg382 14693814
25. Yasumi M Sakisaka T Hoshino T Kimura T Sakamoto Y Yamanaka T Ohno S Takai Y Direct binding of Lgl2 to LGN during mitosis and its requirement for normal cell division J Biol Chem 2005, 280(8):6761-6765. 10.1074/ jbc.C400440200 15632202
26. Mori Y Kono K Matsumoto Y Fujii H Yamane T Mitsumata M Chen WT The expression of a type II transmembrane serine protease (Seprase) in human gastric carcinoma Oncology 2004, 67(5-6):411-419. 10.1159/000082926 15713998
27. Iwasa S Okada K Chen WT Jin X Yamane T Ooi A Mitsumata M Increased expression of seprase, a membrane-type serine protease, is associated with lymph node metastasis in human colorectal cancer Cancer Lett 2005, 227(2):229-236. 10.1016/j.canlet.2004.06.030 16196122
28. Jin X Iwasa S Okada K Mitsumata M Ooi A Expression patterns of seprase, a membrane serine protease, in cervical carcinoma and cervical intraepithelial neoplasm Anticancer Res 2003, 23(4):3195-3198. 12926053
29. Andreasen PA Kjoller L Christensen L Duffy MJ The urokinase-type plasminogen activator system in cancer metastasis: A review Int J Cancer 1997, 72(1):1-22. 10.1002/ (SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z 9212216
30. Duffy MJ Duggan C The urokinase plasminogen activator system: A rich source of tumour markers for the individualised management of patients with cancer Clin Biochem 2004, 37(7):541-548. 10.1016/ j.clinbiochem.2004.05.013 15234235
31. Fujita M Khazenzon NM Bose S Sekiguchi K Sasaki T Carter WG Ljubimov AV Black KL Ljubimova JY Overexpression of beta1-chain-containing laminins in capillary basement membranes of human breast cancer and its metastases Breast Cancer Res 2005, 7(4):R411-421. 1175051 15987446 10.1186/bcr1011
32. Patarroyo M Tryggvason K Virtanen I Laminin isoforms in tumor invasion, angiogenesis and metastasis Semin Cancer Biol 2002, 12(3):197-207. 10.1016/S1044-579X(02)00023-8 12083850
33. Yu L Mikloucich J Sangster N Perez A McCormick PJ MyoR is expressed in nonmyogenic cells and can inhibit their differentiation Exp Cell Res 2003, 289(1):162-173. 10.1016/S0014-4827(03)00252-0 12941614
34. Mathas S Janz M Hummel F Hummel M Wollert-Wulf B Lusatis S Anagnostopoulos I Lietz A Sigvardsson M Jundt F Johrens K Bommert K Stein H Dorken B Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma Nat Immunol 2006, 7(2):207-215. 10.1038/ni1285 16369535
35. Schmalbach CE Chepeha DB Giordano TJ Rubin MA Teknos TN Bradford CR Wolf GT Kuick R Misek DE Trask DK Hanash S Molecular profiling and the identification of genes associated with metastatic oral cavity/pharynx squamous cell carcinoma Arch Otolaryngol Head Neck Surg 2004, 130:295-302. 10.1001/archotol.130.3.295 15023835
36. Deryugina EI Quigley JP Matrix metalloproteinases and tumor metastasis Cancer Metastasis Rev 2006, 25(1):9-34. 10.1007/s10555-006-7886-9 16680569
37. Chakraborti S Mandal M Das S Mandal A Chakraborti T Regulation of matrix metalloproteinases: An overview Mol Cell Biochem 2003, 253(1-2):269-285. 10.1023/A:1026028303196 14619979
38. Duffy MJ Duggan C The urokinase plasminogen activator system: A rich source of tumour markers for the individualised management of patients with cancer Clin Biochem 2004, 37(7):541-548. 10.1016/ j.clinbiochem.2004.05.013 15234235
39. Hirota K Semenza GL Regulation of angiogenesis by hypoxia-inducible factor 1 Crit Rev Oncol Hematol 2006, 59(1):15-26. 10.1016/ j.critrevonc.2005.12.003 16716598
40. Choi KS Bae MK Jeong JW Moon HE Kim KW Hypoxia-induced angiogenesis during carcinogenesis J Biochem Mol Biol 2003, 36(1):120-127. 12542982
41. Vaupel P The role of hypoxia-induced factors in tumor progression Oncologist 2004, 9(Suppl 5):10-17. 10.1634/theoncologist.9-90005-10 15591418